SAV1: A Potential Drug Target and Biomarker (G60485)

Target Name: SAV1

NCBI ID: G60485

SAV1

SAV1: A Potential Drug Target and Biomarker

SAV1 (Salvador Family World Domain Containing Protein 1) is a protein that is expressed in various tissues throughout the body, including the brain, heart, liver, and kidneys. It is a member of the Salvador family of proteins, which are characterized by the presence of a specific domain in their amino acid sequence. SAV1 is unique among Salvador family proteins because it is a world-domain containing protein, meaning that it contains a conserved domain that is found in multiple different protein species.

The Salvador family of proteins is important for cell signaling and transcriptional regulation. The conserved domain of SAV1 is thought to play a role in this function, as it is involved in the regulation of gene expression and cell signaling. SAV1 has also been shown to interact with various transcription factors, including NF-kappa-B, AP-1, and STAT3.

One of the potential applications of SAV1 as a drug target is its role in the regulation of inflammation. SAV1 has been shown to be involved in the regulation of inflammation-related genes, including those that are involved in the production of pro-inflammatory cytokines. This suggests that SAV1 may be a useful target for the development of anti-inflammatory drugs.

Another potential application of SAV1 as a drug target is its role in the regulation of cellular signaling pathways. SAV1 has been shown to be involved in the regulation of various signaling pathways, including the PI3K/Akt signaling pathway. This suggests that SAV1 may be a useful target for the development of drugs that target this pathway.

SAV1 is also of interest as a potential biomarker for various diseases. Its expression has been shown to be elevated in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. This suggests that SAV1 may be a useful biomarker for the diagnosis and treatment of these diseases.

In conclusion, SAV1 is a unique and important protein that has the potential to be a drug target or biomarker. Further research is needed to fully understand its function and the potential applications of SAV1 as a drug.

Protein Name: Salvador Family WW Domain Containing Protein 1

Functions: Regulator of STK3/MST2 and STK4/MST1 in the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS1/2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. SAV1 is required for STK3/MST2 and STK4/MST1 activation and promotes cell-cycle exit and terminal differentiation in developing epithelial tissues. Plays a role in centrosome disjunction by regulating the localization of NEK2 to centrosomes, and its ability to phosphorylate CROCC and CEP250. In conjunction with STK3/MST2, activates the transcriptional activity of ESR1 through the modulation of its phosphorylation

The "SAV1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SAV1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets